Managing and Monitoring Cardiotoxic Risks During Cancer Treatment
September 30th 2024Aaron Adkisson, PharmD, discusses the importance of considering factors such as age, gender, and cardiovascular comorbidities when monitoring and managing cardiotoxic risks in patients with cancer. also emphasizing patient education on recognizing early heart failure symptoms.
Read More